Clinical Trial Update: Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy male volunteers assessing safety and pharmacokinetics of two investigational agents, HIP1503 and HGP1103, with Overactive Bladder liste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• HGP1103
• HIP1503

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Overactive Bladder | Phase 1 | Status: COMPLETED